Germany Dry Powdered Inhaler Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025
Germany dry powdered inhaler market is anticipated to grow at a substantial rate of around 3.7% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the dry powdered inhaler market. Major factors that augment the growth of the dry powdered inhaler market in the country include the significant prevalence of respiratory diseases such as asthma and COPD coupled with increasing geriatric population and growing focus towards the development of therapeutics to treat respiratory diseases.
According to the International Monetary Fund, in
2017, the population of the country was about 80 million and the share of the
geriatric population is around 21%. Major companies working in the field of
respiratory drug and device industry. Ingelheim based Boehringer Ingelheim
International GmbH collaborated with Weill Cornell Medicine in February 2017.
The collaboration aims to find new treatment approaches for chronic pulmonary
diseases. The three-year collaboration aimed to develop novel treatments that
could stop and decrease the progression of COPD.
To Request a Sample of our Report on Germany Dry
Powdered Inhaler Market: https://www.omrglobal.com/request-sample/germany-dry-powdered-inhaler-market
Germany dry powdered inhaler market is segmented
based on type, application, and end-user. Based on the type, preventive,
reliever, and long-acting bronchodilators dry powdered inhalers are analyzed.
The preventive dry powdered inhaler segment led the global dry powdered inhaler
market in 2018. Preventive inhalers are most widely used in the treatment of
asthma in children and adults. These inhalers do not entail side effects for
long-term use, and exceptionally decreases the possibility of an asthma
exacerbation. The preventive inhalers further reduce the airways swelling and
hence, are recommended for regular use by the physician. Some of the preventive
inhalers available in the market include Budesonide and Fluticasone. Moreover,
based on the application, the market has been classified into asthma and COPD
diseases. In addition, based on the end-user, homecare and hospitals and
clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A full Report of Germany Dry Powdered Inhaler Market is
Available at: https://www.omrglobal.com/industry-reports/germany-dry-powdered-inhaler-market
Germany Dry Powdered Inhaler Market Segmentation
By Type
·
Preventive Inhaler
·
Reliever Inhaler
·
Long Acting Bronchodilators Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
AstraZeneca PLC
·
Bespak
·
Boehringer Ingelheim International GmbH
·
Chiesi Farmaceutici S.P.A.
·
GlaxoSmithKline PLC
·
H&T Presspart Manufacturing Ltd.
·
Koninklijke Philips N.V.
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Teicos Pharma Ltd.
·
Teva Pharmaceuticals Industries Ltd.
·
Vitalograph Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion
Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment